Invention Grant
- Patent Title: (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
- Patent Title (中): （杂芳基）芳基环丙胺化合物作为LSD1抑制剂
-
Application No.: US14352711Application Date: 2012-10-22
-
Publication No.: US09487512B2Publication Date: 2016-11-08
- Inventor: Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Angeles Estiarte Martinez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria
- Applicant: ORYZON GENOMICS, S.A.
- Applicant Address: ES Cornella de Llobregat (Barcelona)
- Assignee: Oryzon Genomics S.A.
- Current Assignee: Oryzon Genomics S.A.
- Current Assignee Address: ES Cornella de Llobregat (Barcelona)
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner
- Priority: EP11382325 20111020; EP11382331 20111027
- International Application: PCT/EP2012/070898 WO 20121022
- International Announcement: WO2013/057320 WO 20130425
- Main IPC: C07D451/04
- IPC: C07D451/04 ; C07D309/04 ; C07D309/14 ; C07D215/42 ; C07D221/20 ; C07D223/12 ; C07D401/04 ; C07D401/12 ; C07D405/12 ; C07D417/12 ; C07D205/04 ; C07D207/09 ; C07D207/14 ; C07D209/96 ; C07D211/26 ; C07D211/56 ; C07D211/58
Abstract:
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
Public/Granted literature
- US20150025054A1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS Public/Granted day:2015-01-22
Information query
IPC分类:
